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Acute,  acalculous  cholecystitis  is a  serious, often  fatal  disease  that is seen among 
patients suffering with bacterial sepsis, burns, or trauma, including surgical trauma, 
and cancer  (1).  In  1921,  F.  C.  Mann  (2)  of the Mayo Clinic induced acute inflam- 
mation  and  hemorrhage  in  the  gall  bladder  of  dogs  by  intravenous  injection  of 
solutions  of sodium  hypochloride.  Mann's  experiments  (2)  indicated  that  the  gall 
bladder  could  be  injured  by  intravenous  injection  of a  known  chemical  substance 
and/or a chain of events set in motion by such an injection. 
Factor  XII  (Hageman  factor)  can  be  activated  by  bacterial  endotoxin  and  by 
exposure of plasma to collagen  (3, 4). It is possible in the clinical settings mentioned 
above that induction of acute cholecystitis results from the activation of the intrinsic 
pathway of coagulation leading to generation of mediators of inflammation. 
To test this hypothesis we injected dogs and monkeys intravenously with chemically 
defined  polyphenol activators  of factor XII,  with  Escherichia  coli endotoxin, or with 
buffered saline and observed the effects of systemic activation of factor XII-dependent 
pathways on the gall bladder and other tissues. The results of these experiments  are 
described below. 
Materials and Methods 
Experimental Protocol.  12 mongrel male dogs that weighed between 8 and  15 kg, and 3 male 
African Green Monkeys (Cercopithecus aethiops) that weighed between 4 and 6 kg, were used. The 
animals  were  anesthetized  by  intravenous  injection  of  pentobarbital,  and  under  surgical 
conditions the abdomen was opened and the gall bladder visualized. Besides the gall bladder, 
the stomach, duodenum, small bowel, colon, mesentery, liver, and spleen were clearly visible in 
the operative field. 
Animals were injected in the femoral vein with  10  -4 M  solutions of ellagic acid  (K and  K 
Laboratories,  Inc.,  Plainview,  N.  Y.),  rutin  (Sigma  Chemical  Co.,  St.  Louis,  Mo.),  or with 
lipopolysaccharide W  E.  coli O128:B12  (Difco Laboratories,  Detroit,  Mich.),  all dissolved in 
phosphate-buffered  physiologic saline  (PBS), 1 or with  PBS in comparable  volume as control 
according to the plan in Table I. 
Blood  samples  were  obtained  before  injection  of solutions  of ellagic  acid,  rutin,  E.  coli 
endotoxin,  or  PBS,  at  intervals  thereafter  either  by  venopuncture  with  plastic  syringes  or 
through  a  polyethylene catheter implanted  in the femoral  vein, and  anticoagulated  with  Na 
citrate in chilled plastic tubes for studies described below. 
The gall bladder and other viscera were observed for 1 h after injection of activator substance 
or control PBS, and photographs  taken at different intervals during this period. At the end of 
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TABLE  I 
Activator substance  Dose 
Animals 
Dogs  Monkeys 
mg/kg body wt 
Ellagic acid  0.5  3  3 
Rutin  0.5  3  -- 
E. coli endotoxin  1.0  3  -- 
PBS (control)  3  -- 
this period the animals were sacrificed  by injection of a lethal dose of pentobarbital. They were 
subjected to complete post-mortem examination, and specimens of gall bladder, liver, stomach, 
duodenum, small bowel, colon, mesentery, kidney, skeletal  muscle, diaphragm, skin, heart, 
lung, and brain were fixed in Zenker's solution made 5% in acetic acid, washed, embedded in 
paraffin, sectioned, and stained with hematoxylin and eosin for light microscopic examination. 
Photomicrographs were  taken on a  Leitz photomicroscope (E.  Leitz, Inc., Rockleigh, N. J.) 
with Kodachrome II film (Eastman Kodak Co., Rochester, N. Y.). 
Plasma Samples.  Platelets and other formed elements were removed by centrifugation in 
plastic tubes at 4°C, and plasma was pipetted with plastic pipette tips into plastic tubes and 
stored at -70°C. 
Determination of Partial Thromboplastin Time (PTT).  A fibrometer (Baltimore Biological  Lab- 
oratories,  Baltimore, Md.), plastic pipette tips, plastic tubes, and the following reagents were 
used: Celite (Filter Aid, Fisher Scientific Co.,  Pittsburgh, Pa.)  in PBS in a concentration of 5 
mg/ml, 0.05 M CaClz in glyoxaline buffer, and rabbit brain cephalin (Sigma Chemical Co.) in 
PBS.  For measurement of activated PTT, 0. I ml of plasma was pipetted in a plastic reaction 
vessel and warmed at  37°C  for  60  s.  0.1  ml of Celite suspension was  then added,  and the 
mixture was warmed for 60 s. 0.05  ml of cephalin suspension and 0.05  ml of CaCI2 solution 
were then added, and the timer and probes were started. For the measurement of unactivated 
PTT, 0.1  ml of PBS was used instead of 0.1  ml of Celite suspension; the assay was otherwise 
performed  identically. All values presented represent the mean of duplicate determinations. 
The coefficient  of variation in activated or unactivated PTT was <6%. 
Determination of Fibrinolytic Activity.  The euglobulin clot  lysis time of plasma samples was 
measured  using the  technique of Ogston et  al.  (5). All determinations were  performed  in 
duplicate, and  the  values shown  represent  the  mean of duplicate determinations. Plasmin 
activity was also measured according to the technique of Friberger et al_ (6) using chromogenic 
substrate S-2251  (H-o-Val-Leu-Lys-pNA) (Ortho  Diagnostics Inc., Raritan, N. J.).  Plasmin 
activity according to this method is expressed  in nkat/ml. The titer of fibrinogen clottable with 
thrombin was measured according to the technique described by Biggs (7). 
Measurement of Serum Complement.  Plasma samples were clotted by addition of CaClz and 
centrifuged. CHr,0 was measured in the serum supernate according to the method described by 
Rapp and Borsos (8). 
Results 
Morphologic  Observations.  Within  3-5  min  of  intravenous injection in  dogs  and 
monkeys of ellagic acid, rutin, or E. coli endotoxin, spasm of small arteries in the body 
and fundus of the gall bladder occurred in association with segmental spasm of larger 
branches of the cystic artery.  The blue color of the  gall bladder turned gray,  then 
white.  These changes progressed  until only the  major branches of the cystic artery 
were  visible to  the  naked eye;  the  smaller vessels  having so  greatly contracted.  In 
general, these  changes  and  ensuing changes  described  below were  confined to  the 
body and fundus of the gall bladder and spared the ampulla. Approximately t5-20 
min after  injection of activator substances, serosal  veins and  lymphatics appeared 
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gressed until the serosa developed a  reticulated or striated appearance as a  result of 
spreading apart of connective tissue bundles by edema fluid. Approximately 30 min 
after injection of activator substances,  petechial hemorrhages were apparent  in the 
serosa of the gall gladder (Figs.  1 and 2). 
The petechial hemorrhages sometimes enlarged with  the cessation of vasospasm 
and  the  reappearance  to  the  naked  eye of small  serosal  arteries,  which  occurred 
between 30 and 60 min after the injection of activator. 
In both dogs and monkeys the changes described above were confined to the gall 
bladder  and  were  not  observed  in  other  abdominal  viscera  visible  through  the 
abdominal incision. The severity of changes in the gall bladder varied somewhat from 
animal  to  animal  in  both  dogs  and  monkeys, but  occurred  in  every animal.  No 
changes occurred grossly in the gall bladders or other organs of sham-operated dogs 
injected intravenously with comparable volumes of PBS. 
On microscopic examination of the gall bladders from dogs injected intravenously 
with  rutin  or ellagic acid,  marked  edema of the  serosa  and  muscularis  with  focal 
hemorrhage was observed  (Fig.  3).  Focal necrosis of arteries and  veins was  present 
and the walls of both were often markedly infiltrated by polymorphonuclear neutro- 
phils  (Fig. 4).  Small veins were engorged with polymorphonuclear neutrophils that 
were adherent to endothelium, between endothelial cells and extravasated  (Fig. 5). 
The lumina of some vessels  in the wall of the gall bladder were occluded by thrombi 
(Fig. 6). These changes were confined to the muscularis and serosa, although hemor- 
rhage  was  sometimes  observed just  below  the  mucosa  (Fig.  3).  The  mucosa  itself 
appeared  normal  (Fig.  2).  Gall  bladders  of monkeys  injected  intravenously  with 
ellagic acid showed the same histologic changes, though of lesser severity. In dogs and 
monkeys, no microscopic changes were observed in other abdominal viscera (Fig. 7), 
including those supplied by other branches of the celiac artery, the kidneys, skeletal 
muscle, heart,  or skin.  Margination  of polymorphonuclear neutrophils was  seen in 
pulmonary blood vessels,  and alveolar capillaries contained an increased number of 
polymorphonuclear neutrophils  (Figs.  8 and 9). In some animals pulmonary edema 
was present and in others focal extravasation of erythrocytes from alveolar capillaries 
had occurred. 
Microscopic  examination  of tissue  sections  from  dogs  injected  with  endotoxin 
revealed vascular thrombosis and necrosis, edema, and hemorrhage in the serosa and 
muscularis  of the  gall  bladder.  This was  not  accompanied by infiltration of these 
vascular  structures  by  polymorphonuclear neutrophils.  In  addition,  microthrombi 
were present  in small pulmonary vessels,  including alveolar capillaries, myocardial 
vessels, and in the kidney. 
No changes were observed in  the  gall  bladder,  lungs,  or other viscera of sham- 
operated dogs that were injected intravenously with comparable volumes of PBS. 
Studies  on  Plasma.  Intravenous injection of dogs with ellagic acid, rutin, or E.  coil 
endotoxin  resulted  in  shortening  of the  unactivated  PTT  but  not  of the  Celite- 
activated PTT. Intravenous injection of monkeys with ellagic acid resulted in marked 
prolongation of both the activated and unactivated  PTT. The euglobulin clot lysis 
time of dogs injected with ellagic acid, rutin, or E. coli endotoxin was greatly shortened. 
This change was  associated with a  fall in  fibrinogen titer and,  in  the case of dogs 
injected with ellagic acid or E.  coli endotoxin, activated capacity of plasma to digest 
chromogenic substrate S-2251. It was not possible to measure the euglobulin clot lysis 84 C.  G.  BECKER,  T.  DUBIN,  AND  F.  GLENN 
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Substance 
Subject  injected 
Unactivated PTT  Euglobulin clot  Plasmin 
lysis time  activity  Fibrinogen titer 
0min  15min  0min  15min  0min  15min  0min  15min 
s  rain  nkat/ml 
Dog 21  Ellagic acid  185.2  119.7  68  8  0  0.08  1:64  1:32 
Dog 31  Rutin  147.4  110.2  133  33  0  0  1:64  1:8 
Dog 30  Endotoxin  350.2  238.2  96  2 t  0  0.24  1:64  1:16 
Dog 20  PBS  168.2  168.3  64  63  0  0  1:64  1:64 
Monkey 2  Ellagic acid  333.7  >1,200.0  198  *  0  0.32  1:64  <1:1 
* Not clottable with thrombin. 
time  in  monkey  plasma  after  intravenous  injection  of  ellagic  acid  because  the 
fibrinogen titer fell to a dilution of < 1:1; however, plasmin activity was demonstrable 
in these samples by using chromogenic substrate S-2251. The effects on plasma of the 
animals whose tissues are illustrated in Figs.  1-9 are seen in Table II. 
The  use  of coagulation  assays  to  demonstrate  consumption  of factor  XII  or  of 
prekallikrein  in  dog  or  in  monkey plasma after  intravenous  injection  of activator 
substances was precluded by the presence of either activated clotting proteins and/or 
residual activating substances. 
No significant changes were observed in CHs0 in these studies. 
Discussion 
In experiments described above it has been demonstrated that intravenous injection 
in dogs and monkeys ofellagic acid or of rutin, which are known polyphenol activators 
of factor XII, induces acute inflammation in blood vessels of the serosa and muscularis 
of the gall bladder.  Margination of polymorphonuclear neutrophils was also seen to 
a  lesser extent  in  the lung,  sometimes with pulmonary edema and  focal necrosis of 
FIG.  1.  Petechial hemorrhages are present in the serosa of the body and fundus of the gall bladder 
of dog No. 2 l, sacrificed 1 h after injection of ellagic acid in the femoral vein. 
Fro.  2.  The muscularis and serosa of the body and fundus of the gall bladder described above are 
greatly thickened by edema. The mucosa is grossly normal. 
FIG.  3.  Hemorrhage is present in the muscularis and in the submucosa of the gall bladder of dog 
No. 31, injected intravenously with rutin. Hematoxylin and eosin. ×  80. 
Fio.  4.  The  walls  of veins  and  an  artery  are  necrotic  and  infiltrated  by  polymorphonuclear 
neutrophils in the muscularis of the gall bladder of dog No. 21, injected intravenously with ellagic 
acid. Hematoxylin and eosin. ×  500. 
Fxc.  5.  A  small vein  in  the  muscularis of the  gall  bladder  described  in  Fig.  4  is choked with 
polymorphonuclear neutrophils, many of which are marginated and some of which are emigrating. 
Edema spreads smooth muscle fibers apart. Hematoxylin and eosin. ×  500. 
Fro.  6.  Necrosis and thrombosis of a  small artery deep to the gall bladder mucosa is shown in a 
microscopic section of dog No.  31, injected  intravenously with rutin.  Hematoxylin and eosin. × 
500. 
FIG.  7.  The pancreatic parenchyma of dog No. 21, injected intravenously with ellagic acid, and its 
blood vessels are histologically normal. Hematoxylin and eosin. ×  200. 
Fro.  8.  Polymorphonuclear neutrophils fill the lumen and appear to be adherent to the endothe- 
lium of a  branch of the pulmonary artery in dog No. 21. Hematoxylin and eosin. X 500. 
Flo.  9.  In the lungs of monkey No. 2, injected intravenously with ellagic acid, increased numbers 
of  polymorphonuclear  neutrophils  are  present  in  alveolar  capillaries  that  are  focally  injured, 
allowing extravasation of erythrocytes. Hematoxylin and eosin. X  1,250. 86  INDUCTION OF CHOLECYSTITIS BY ACTIVATION OF  FACTOR XII 
alveolar  capillaries.  Blood  vessels  in  other  organs  were  not  affected.  Intravenous 
injection of E. coli endotoxin in dogs also resulted in necrosis and thrombosis of blood 
vessels that  was  especially severe in  the  gall  bladder,  but  which  occurred  in  other 
organs also. 
These  morphologic  changes  are  associated  with,  and  presumably  the  result  of, 
activation of factor XII-dependent pathways and generation of kinin activity because 
it  could  be  demonstrated  that  coagulation  and  fibrinolytic  pathways  had  been 
activated  in  the  dog  and  monkey.  Activated  factor  XII  converts  prekallikrein  to 
kallikrein, and several laboratories have presented evidence indicating that kallikrein 
converts plasminogen to plasmin (9,  10). Ellagic acid and E. coli endotoxin are known 
to  activate  factor  XII-dependent  pathways  in  vitro  and  in  vivo,  and  it  has  been 
demonstrated  in this laboratory that  rutin can activate factor XII-dependent path- 
ways in human plasma in vitro (11-14). It is of interest that intravenous injection of 
dogs  with  ellagic  acid,  rutin,  or  E.  coli  endotoxin  resulted  in  shortening  of the 
unactivated  PTT  but  not  of the  Celite-activated  PTT.  These  results  reconcile  the 
observations of Botti and Ratnoff (12)  and of Girolami et al.  (15)  and indicate that 
in  the  dog,  shortening  of  the  unactivated  PTT  is  a  more  sensitive  indicator  of 
activation of the intrinsic pathway. Intravenous injection of monkeys with ellagic acid 
induced  marked increases in both the unactivated and Celite-activated PTT, which 
suggests consumption of coagulation factors. The marked consumption of fibrinogen 
observed in monkey plasma supports this explanation. 
Plasma  samples  from  dogs  injected  intravenously  with  rutin  were  unable  to 
hydrolyze chromogenic substrate S-2251, even though the euglobulin clot lysis times 
and fibrinogen titers of these samples were decreased. In contrast, plasma from dogs 
injected with ellagic acid or E.  coli endotoxin, or from monkeys injected with ellagic 
acid were able to digest S-2251. We have no explanation for this discrepancy. 
Botti and Ratnoff (12) have demonstrated that intravenous injection of ellagic acid 
in dogs in similar doses led to activation of factor XII. However, these investigators 
did  not  describe changes  in  the  gall bladder or the lung consequent  to injection  of 
ellagic acid. 
The observation that  injury to blood vessels was limited to the  gall bladder and 
lung  suggests  that  the  blood  vessels  in  these  organs  are  especially  responsive  to 
bradykinin.  Because  it  has  been  shown  that  bradykinin  stimulates  contraction  of 
endothelial cells of postcapillary venules resulting in increased permeability (16), it is 
reasonable to assume that  endothelium  of venules in the gall bladder and lung are 
especially sensitive to bradykinin. However, vasospasm of arteries in the gall bladder, 
but  not  those  of adjacent  organs,  was  the  earliest  change  that  we observed, which 
suggests  that  smooth  muscle  of branches  of the  cystic  artery  are  also  sensitive  to 
bradykinin and respond by constricting. In this connection it is known that umbilical 
cord vessels and  the  ductus  arteriosus constrict  in  response to bradykinin,  whereas 
many other vessels dilate (17,  18). 
It should  be pointed out  that  some controversy exists concerning the presence of 
kininogenase  in  dog  plasma.  Saito  et  al.  (19)  were  unable  to  correct  the  PTT  of 
human  plasma  deficient  in  prekallikrein  with  dog  plasma,  nor  were  they  able  to 
precipitate kallikrein from dog plasma using rabbit antiserum to human kallikrein. In 
contrast,  Nakahara  (20)  was  able  to  generate  bradykinin  activity  measured  by 
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contained  potent  inhibitors  of kininogenase,  which  may  explain  the  difficulty  in 
demonstrating kininogenase activity. 
The vasospasm and edema that we observed in the wall of the gall bladder certainly 
indicated  kinin-like activity. This may have been generated  as the result  of kinino- 
genase activity in plasma. It is also conceivable that it might have been generated as 
the result of activity of kininogenases associated with blood vessels in the wall of the 
gall bladder. The latter hypothesis might explain the localization of the inflammatory 
response to vessels of the gall bladder and of the lung. 
It was also observed that  1 h  after intravenous  injection  of ellagic acid or rutin, 
margination  and  emigration  of  polymorphonuclear  neutrophils  had  occurred  in 
venules  of the  gall  bladder  and  that  the  walls  of some  veins  and  arteries  were 
extensively infiltrated with polymorphonuclear neutrophils. The nature of the chem- 
otactic stimulus  is unknown,  but it is conceivable that it is kallikrein generated as a 
consequence to activation of factor XII (21). According to this hypothesis, activation 
of factor XII-dependent  pathways  led  to  the  production  of bradykinin,  which  en- 
hanced vascular permeability to larger molecules, including kallikrein, which in turn 
stimulated  the  migration of polymorphonuclear neutrophils  into  the walls of blood 
vessels.  Alternatively,  activation  of the  fibrinolytic  pathway  with  the  formation  of 
plasmin  may have led  indirectly  to the  generation  of chemotactic  factors from the 
complement system (22, 23). The fact that CHs0 did not fall does not exclude limited 
and/or local activation of C5. 
Margination  and emigration of polymorphonuclear neutrophils  was present  to a 
much  greater degree in  the  gall bladders  of dogs treated with  ellagic  acid  or rutin 
than in dogs treated with endotoxin. All these substances are known to activate factor 
XII, but endotoxin can also activate both the classical and alternative pathways of 
the complement system (13), possibly leading to a rapid sequestering of polymorpho- 
nuclear neutrophils and preventing their accumulation in the gall bladder. 
It  is  of  interest  that  margination  of  polymorphonuclear  neutrophils  was  also 
observed in vessels of the lung, sometimes with the development of pulmonary edema 
after injection  with ellagic acid or rutin.  This observation also suggests that certain 
vascular beds are more sensitive than others to products generated as a consequence 
of  activation  of  factor  XII.  Desai  et  al.  (24)  have  demonstrated  that  the  fifth 
component  of  complement  is  chemotactic  in  the  lung  of  hamsters,  but  to  our 
knowledge the chemotactic activity of kallikrein in the lung has not been measured. 
However, exposure of hamsters to a dust of quercetin, the aglucone of rutin, results in 
recruitment  of polymorphonuclear leukocytes through  intrapulmonary airway walls 
(25). 
Margination  and  emigration  of polymorphonuclear neutrophils  was observed in 
ear chambers in  rabbits by Graham et  al.  (26)  after local application of factor XII 
and ellagic acid.  We did  not observe these changes  in  the skin or any organs other 
than the gall bladder or lung when ellagic acid or rutin were injected intravenously. 
There is no ready explanation  for these differences, but it is conceivable that vessels 
of the ear became more responsive to products of factor XII activation after implan- 
tation of the ear chamber. It might be similarly argued that surgical exposure of the 
gall  bladder  also  made  its  vasculature  more  responsive  to  products  of factor  XII 
activation. This seems unlikely because:  (a) we did not observe these changes in other 
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(b) inflammatory changes were equally marked in the portion of the gall bladder wall 
attached  to  the  liver and  not  subject  to  manipulation;  and  (c)  inflammation  was 
observed in  the  gall  bladder  after intravenous  injection  of activators of factor XII 
when even touching the gall bladder was scrupulously avoided. 
The observations described above support the hypothesis that activation of factor 
XII-dependent pathways can lead to development of acute, acalculous cholecystitis. 
When  this  syndrome  occurs  in  patients  with  bacterial  sepsis,  bacterial  endotoxin 
might serve as the substance activating the intrinsic pathway of coagulation. Activa- 
tion of factor XII by exposure of plasma to collagen or the release of tissue factor and 
activation of factorVII might lead to the development of acute cholecystitis in patients 
with  burns  or other trauma.  The latter explanations  might apply to patients  with 
widespread metastases and foci of necrotic tumor. In addition, plasminogen activator 
from tumor cells might initiate the chain of events leading to acalculous cholecystitis 
(27). 
The fact that intravenous injection of known polyphenol activators of the intrinsic 
coagulation  pathway  can  lead  to  the  development  of acute  vasculitis  in  the  gall 
bladders  of dogs  and  monkeys  may  provide  an  important  insight  into  both  the 
epidemiology of cholecystitis  in  man  and  into  the  mechanisms underlying  the seg- 
mental nature of vascular injury. Polyphenols are common constituents of plants and 
are  commonly ingested.  Furthermore,  it  has  been  demonstrated  in  this  laboratory 
that  constituents  of tobacco  smoke contain  rutin  or  rutin-like  moieties capable of 
activating factor XII (14).  It is conceivable that repetetive inhalation of such material 
might lead to the development of inflammation in the gall bladder and that cigarette 
smoking contributes to the development of cholecystitis in man. 
Summary 
Acute, acalculous cholecystitis is seen among patients suffering with bacterial sepsis, 
burns,  trauma, or cancer;  clinical conditions  that could lead to activation of factor 
XII-dependent pathways and result in inflammation of the gall bladder. To test this 
hypothesis,  dogs  were  injected  intravenously  with  ellagic  acid  or  rutin,  known 
polyphenol activators of factor XII, or with Escherichia  coli endotoxin,  also known to 
activate factor XII, and  monkeys were injected  intravenously with  ellagic  acid.  In 
both species, in  vivo activation of factor XII-dependent pathways with  polyphenol 
activator resulted in rapid and selective development of acute vasculitis in the serosa 
and muscularis of the gall bladder and margination of polymorphonuclear neutrophils 
in pulmonary blood vessels. Intravenous injection of E. coli endotoxin in dogs resulted 
in  necrosis  and  thrombosis of vessels that  were especially severe in  the  serosa  and 
muscularis of the gall bladder but also present in vessels of many other organs. These 
observations indicate that blood vessels of the gall bladder and, to a lesser degree, the 
lung are especially sensitive to injury consequent  to in vivo activation of factor XII- 
dependent pathways and, in view of the common ingestion of plant polyphenols, may 
provide important insight into the pathogenesis of cholecystitis in man. 
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